38543085|t|Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer.
38543085|a|The NLR family pyrin domain containing 3 (NLRP3) promotes the growth of colorectal cancer (CRC). However, the therapeutic effect of NLRP3 inhibition on CRC cell progression is controversial. This study comparatively investigated the therapeutic effect of a pharmacological NLRP3 inhibitor, glibenclamide (gli), and the post-translational suppression of NLRP3 by miR-223 on CRC cell progression in HCT-116 and HCT-15 cells. LPS and ATP were used to activate Gli-treated and LSB-hsa-miR-223-3p (WTmiR-223)-expressing HCT-116 cells. NLRP3.AB.pCCL.sin.cPPT.U6.miR-223-Decoy.hPGK.GFP.WPRE plasmid (DmiR-223) was the negative control for miR-223 expression. NLRP3, gasdermin D, and BAX expressions were analyzed using western blotting. Real-time PCR detected the RNA expression of autophagy-related genes ATG5, BECN1, and miR-223 in non-transfected cells. ELISA analyzed IL-1beta and IL-18 in the medium. MTS-1, annexin V, wound-healing, and sphere-invasion assays were used to assess cell viability and progression. A multiplex cytokine assay detected proinflammatory cytokine secretion. LPS-ATP-activated NLRP3 produced gasdermin D cleavage, released IL-1b and IL-18, and activated cell migration and sphere invasion. In contrast, reduced cell growth, miR-223 expression, IFN-gamma, CXCL10, and LIF secretion were found in cells after inflammasome activation. Both gli and WTmiR-223 induced autophagy genes ATG5 and BECN1 and reduced the NLRP3 activation and its downstream proteins. However, while gli had a limited effect on the production of IFN-gamma, CXCL10, and LIF, WTmiR-223 increased the release of those cytokines. In addition, gli did not suppress cell growth, while WTmiR-223 promoted apoptosis. Notably, neither gli nor WTmiR-223 effectively prevented sphere invasion. These data suggest that, while WTmiR-223 could have a better anticancer effect in CRC compared to gli, the sole usage of miR-223-mediated NLRP3 suppression may not be sufficient to prevent CRC metastasis.
38543085	16	21	NLRP3	Gene	114548
38543085	40	53	Glibenclamide	Chemical	MESH:D005905
38543085	58	65	miR-223	Gene	407008
38543085	74	91	Colorectal Cancer	Disease	MESH:D015179
38543085	97	133	NLR family pyrin domain containing 3	Gene	114548
38543085	135	140	NLRP3	Gene	114548
38543085	165	182	colorectal cancer	Disease	MESH:D015179
38543085	184	187	CRC	Disease	MESH:D015179
38543085	225	230	NLRP3	Gene	114548
38543085	245	248	CRC	Disease	MESH:D015179
38543085	366	371	NLRP3	Gene	114548
38543085	383	396	glibenclamide	Chemical	MESH:D005905
38543085	398	401	gli	Chemical	MESH:D005905
38543085	446	451	NLRP3	Gene	114548
38543085	455	462	miR-223	Gene	407008
38543085	466	469	CRC	Disease	MESH:D015179
38543085	490	497	HCT-116	CellLine	CVCL:0291
38543085	502	508	HCT-15	CellLine	CVCL:0292
38543085	516	519	LPS	Chemical	MESH:D008070
38543085	524	527	ATP	Chemical	MESH:D000255
38543085	566	569	LSB	Chemical	-
38543085	608	615	HCT-116	CellLine	CVCL:0291
38543085	725	732	miR-223	Gene	407008
38543085	745	750	NLRP3	Gene	114548
38543085	752	763	gasdermin D	Gene	79792
38543085	769	772	BAX	Gene	581
38543085	892	896	ATG5	Gene	9474
38543085	898	903	BECN1	Gene	8678
38543085	909	916	miR-223	Gene	407008
38543085	958	966	IL-1beta	Gene	3553
38543085	971	976	IL-18	Gene	3606
38543085	992	997	MTS-1	CellLine	CVCL:X540
38543085	999	1008	annexin V	Gene	308
38543085	1176	1179	LPS	Chemical	MESH:D008070
38543085	1180	1183	ATP	Chemical	MESH:D000255
38543085	1194	1199	NLRP3	Gene	114548
38543085	1209	1220	gasdermin D	Gene	79792
38543085	1240	1245	IL-1b	Gene	3553
38543085	1250	1255	IL-18	Gene	3606
38543085	1341	1348	miR-223	Gene	407008
38543085	1361	1370	IFN-gamma	Gene	3458
38543085	1372	1378	CXCL10	Gene	3627
38543085	1384	1387	LIF	Gene	3976
38543085	1454	1457	gli	Chemical	MESH:D005905
38543085	1496	1500	ATG5	Gene	9474
38543085	1505	1510	BECN1	Gene	8678
38543085	1527	1532	NLRP3	Gene	114548
38543085	1588	1591	gli	Chemical	MESH:D005905
38543085	1634	1643	IFN-gamma	Gene	3458
38543085	1645	1651	CXCL10	Gene	3627
38543085	1657	1660	LIF	Gene	3976
38543085	1727	1730	gli	Chemical	MESH:D005905
38543085	1814	1817	gli	Chemical	MESH:D005905
38543085	1953	1956	CRC	Disease	MESH:D015179
38543085	1969	1972	gli	Chemical	MESH:D005905
38543085	1992	1999	miR-223	Gene	407008
38543085	2009	2014	NLRP3	Gene	114548
38543085	2060	2074	CRC metastasis	Disease	MESH:D015179
38543085	Negative_Correlation	MESH:D005905	MESH:D015179
38543085	Positive_Correlation	MESH:D005905	3976
38543085	Positive_Correlation	MESH:D005905	8678
38543085	Positive_Correlation	MESH:D000255	3553
38543085	Positive_Correlation	114548	3606
38543085	Positive_Correlation	MESH:D000255	3606
38543085	Positive_Correlation	114548	3553
38543085	Positive_Correlation	MESH:D005905	3458
38543085	Association	114548	407008
38543085	Negative_Correlation	MESH:D005905	114548
38543085	Positive_Correlation	MESH:D000255	114548
38543085	Positive_Correlation	MESH:D005905	9474
38543085	Association	MESH:D008070	79792
38543085	Association	MESH:D015179	407008
38543085	Positive_Correlation	MESH:D008070	3606
38543085	Association	114548	79792
38543085	Positive_Correlation	MESH:D000255	79792
38543085	Association	MESH:D015179	114548
38543085	Positive_Correlation	MESH:D008070	3553
38543085	Association	MESH:D005905	3627
38543085	Positive_Correlation	MESH:D008070	114548

